Dario publishes new research demonstrating digital personalization of pain management with adapted machine learning

Dario's musculoskeletal solution uses data from a biofeedback sensor to drive healthier behaviors and reduce pain new york , march 14, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio)(the "company" or "dario"), a leader in the global digital therapeutics (dtx) market, announced today new research published in pain reports investigating personalized efficacy of digital therapeutics for pain management, linking the reduction of back pain for users in a digital posture training program with the personalization of user journeys adapting machine learning models.     the application of machine learning in digital health solutions is frequently cited as a means of delivering personalized programs, but our present understanding of the implications and outcomes is limited.
DRIO Ratings Summary
DRIO Quant Ranking